Exact Sciences Corporation - Laporan Laba Rugi (TTM)

Exact Sciences Corporation
US ˙ NasdaqCM ˙ US30063P1057

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Exact Sciences Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,321 1,491 1,546 1,712 1,760 1,767 1,852 1,938 2,005 2,084 2,200 2,301 2,406 2,500 2,535 2,612 2,692 2,759 2,828 2,940
Change (%) 12.93 3.64 10.74 2.81 0.42 4.78 4.69 3.44 3.95 5.56 4.57 4.58 3.90 1.40 3.04 3.07 2.47 2.51 3.95
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 325 354 383 419 439 459 483 514 546 661 597 609 630 738 772 826 853 840 855 893
Change (%) 9.03 8.01 9.43 4.94 4.39 5.39 6.34 6.26 21.06 -9.80 2.08 3.38 17.16 4.66 6.99 3.34 -1.55 1.79 4.41
% of Revenue 24.61 23.76 24.76 24.47 24.98 25.96 26.11 26.52 27.25 31.73 27.11 26.47 26.17 29.51 30.45 31.62 31.70 30.45 30.24 30.37
Gross Operating Profit 996 1,137 1,163 1,293 1,320 1,308 1,368 1,424 1,459 1,423 1,604 1,692 1,776 1,762 1,763 1,786 1,839 1,919 1,973 2,047
Change (%) 14.20 2.28 11.17 2.11 -0.90 4.57 4.11 2.42 -2.46 12.70 5.49 5.01 -0.80 0.04 1.32 2.95 4.34 2.83 3.76
% of Revenue 75.39 76.24 75.24 75.53 75.02 74.04 73.89 73.48 72.75 68.27 72.89 73.53 73.83 70.49 69.55 68.38 68.30 69.55 69.76 69.63
SG&A 961 1,071 1,126 1,249 1,370 1,538 1,609 1,682 1,695 1,650 1,624 1,612 1,625 1,646 1,665 1,657 1,665 1,679 1,724 1,773
Change (%) 11.50 5.09 10.97 9.68 12.25 4.59 4.58 0.74 -2.67 -1.52 -0.77 0.83 1.27 1.13 -0.47 0.46 0.89 2.67 2.81
% of Revenue 72.75 71.83 72.84 72.99 77.88 87.05 86.89 86.80 84.53 79.15 73.84 70.07 67.56 65.85 65.68 63.43 61.82 60.87 60.97 60.30
R&D 151 554 626 700 744 386 372 372 388 394 387 385 405 427 442 459 448 431 426 413
Change (%) 267.22 13.01 11.75 6.27 -48.13 -3.45 -0.04 4.15 1.69 -1.93 -0.51 5.36 5.35 3.62 3.85 -2.47 -3.77 -1.29 -2.88
% of Revenue 11.42 37.15 40.51 40.88 42.26 21.82 20.11 19.20 19.33 18.91 17.57 16.72 16.84 17.08 17.45 17.59 16.64 15.63 15.05 14.06
OpEx 1,521 2,073 2,228 2,461 2,648 2,478 2,561 2,668 2,727 2,718 2,703 2,698 2,752 2,809 2,854 2,894 2,920 2,951 3,005 3,079
Change (%) 36.33 7.47 10.48 7.56 -6.42 3.37 4.16 2.24 -0.33 -0.55 -0.20 2.00 2.06 1.62 1.41 0.87 1.07 1.84 2.46
% of Revenue 115.14 139.00 144.14 143.81 150.46 140.21 138.32 137.63 136.03 130.43 122.87 117.27 114.38 112.35 112.59 110.81 108.44 106.95 106.25 104.73
Operating Income -200 -582 -682 -750 -888 -711 -710 -729 -722 -634 -503 -397 -346 -309 -319 -282 -227 -192 -177 -139
Change (%) 190.85 17.30 9.90 18.41 -19.97 -0.15 2.79 -0.96 -12.21 -20.65 -21.05 -12.88 -10.76 3.37 -11.58 -19.50 -15.59 -7.77 -21.43
% of Revenue -15.14 -39.00 -44.14 -43.81 -50.46 -40.21 -38.32 -37.63 -36.03 -30.43 -22.87 -17.27 -14.38 -12.35 -12.59 -10.81 -8.44 -6.95 -6.25 -4.73
Interest Expense -77 -68 -18 -18 -19 -19 -18 -21 -19 -20 -21 -25 -17 -19 -21 -23 -36 -27 -29 -29
Change (%) -11.85 -73.58 1.96 1.10 0.53 -0.74 14.61 -10.79 3.98 8.86 15.47 -31.15 14.45 8.88 10.98 51.32 -24.02 7.53 -1.06
% of Revenue -5.84 -4.56 -1.16 -1.07 -1.05 -1.05 -1.00 -1.09 -0.94 -0.94 -0.97 -1.07 -0.71 -0.78 -0.84 -0.90 -1.32 -0.98 -1.03 -0.98
Net Income -327 -824 -720 -829 -793 -596 -745 -735 -716 -624 -517 -432 -282 -204 -240 -175 -214 -1,029 -1,020 -1,005
Change (%) 151.64 -12.56 15.11 -4.29 -24.92 25.15 -1.46 -2.47 -12.96 -17.13 -16.46 -34.64 -27.64 17.67 -27.15 22.30 380.69 -0.88 -1.43
% of Revenue -24.78 -55.22 -46.59 -48.43 -45.09 -33.71 -40.26 -37.89 -35.73 -29.91 -23.49 -18.76 -11.73 -8.17 -9.48 -6.70 -7.95 -37.29 -36.06 -34.19

Source: Capital IQ

Other Listings
MX:EXAS
DE:EXK € 43.87
IT:1EXAS € 45.32
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista